Supplemental Material - Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline PASI from week 4-40
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This is supplemental material for the manuscript: Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline PASI from week 4-40
创建时间：
2024-01-16
